Content about Drugs

July 3, 2013

Oregon Gov. John Kitzhaber, a Democrat, has signed what the National Association of Community Pharmacy has characterized as groundbreaking reform legislation that applies reasonable standards to how pharmacy benefit managers audit community pharmacies, provides increased transparency into generic prescription drug reimbursement and ensures that PBM administrators of prescription drug claims are registered within the state.

ALEXANDRIA, Va. — Oregon Gov. John Kitzhaber, a Democrat, has signed what the National Association of Community Pharmacy has characterized as groundbreaking reform legislation that applies reasonable standards to how pharmacy benefit managers audit community pharmacies, provides increased transparency into generic prescription drug reimbursement and ensures that PBM administrators of prescription drug claims are registered within the state.

July 2, 2013

A dramatic increase in the number of women dying from opioid painkiller overdoses has health officials alarmed.

NEW YORK — A dramatic increase in the number of women dying from opioid painkiller overdoses has health officials alarmed.

The Centers for Disease Control and Prevention announced Tuesday results of an analysis showing that nearly 48,000 women died of prescription painkiller overdoses between 1999 and 2010, with the rate of women dying this way in 2010 increasing more than five-fold during that time. The number of men who died from prescription painkiller overdoses in 2010 increased by 265% over 1999.

July 1, 2013

CVS/pharmacy has bolstered its mobile app by adding the new Drug Interaction Checker, which is an industry first that allows customers to easily check for potential drug interactions by comparing OTC products with their prescriptions and other OTCs on their smartphones.

WOONSOCKET, R.I. — CVS/pharmacy has bolstered its mobile app by adding the new Drug Interaction Checker, which is an industry first that allows customers to easily check for potential drug interactions by comparing OTC products with their prescriptions and other OTCs on their smartphones.

June 19, 2013

A large majority of Americans are taking prescription drugs, according to a new study by the Mayo Clinic.

ROCHESTER, Minn. — A large majority of Americans are taking prescription drugs, according to a new study by the Mayo Clinic.

The study, published online in the journal Mayo Clinic Proceedings, found that nearly 70% of Americans are taking at least one drug, and more than half are taking two. Most of the drugs are antibiotics, antidepressants and opioid painkillers. Researchers said the data, which came from the Rochester Epidemiology Project, would be valuable because it would give insight into prescribing practices.

June 12, 2013

Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.

NEW YORK — Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.

June 3, 2013

Retail pharmacists will be missing out on as much as a $20 billion opportunity if they don't identify how to consistently and efficiently engage their patients, suggested Jeff Rehling, principal at Edgewood Consulting Group, during a business session Sunday at the recent 2013 GMDC Health & Wellness @ Retail Conference.

SAN ANTONIO — Retail pharmacists will be missing out on as much as a $20 billion opportunity if they don't identify how to consistently and efficiently engage their patients, suggested Jeff Rehling, principal at Edgewood Consulting Group, during a business session Sunday at the recent 2013 GMDC Health & Wellness @Retail Conference. 

June 3, 2013

Another bill to limit dispensing of biosimilars lost Monday, this time in Illinois.

WASHINGTON — Another bill to limit dispensing of biosimilars lost Monday, this time in Illinois.

The state's legislature voted not to advance S.B. 1934, supported by such biotech companies as Amgen and Genentech, which would slow patients' access to knock-off versions of biotech drugs by restricting pharmacists' ability to dispense them. Illinois is the 13th state to defeat such a bill; a similar bill died in Texas' state legislature last week.

May 30, 2013

When does the double-edged sword of generic drug price reductions begin to cut the government agency or health system holding the sword?

That's the question many pharmacy leaders in Canada have for the provincial health system policy-makers who have embarked on a crusade to whack pharmacy reimbursement levels for many lower-cost generic medicines sold under the nation's publicly funded health system.

When does the double-edged sword of generic drug price reductions begin to cut the government agency or health system holding the sword?

That's the question many pharmacy leaders in Canada have for the provincial health system policy-makers who have embarked on a crusade to whack pharmacy reimbursement levels for many lower-cost generic medicines sold under the nation's publicly funded health system. The effort has drawn the ire of pharmacy advocates even as proponents in government and health policy circles tout its cost-saving benefits.

May 29, 2013

Texas has become the latest state to defeat a bill that critics say would limit the reach of knock-off versions of biotech drugs.

WASHINGTON — Texas has become the latest state to defeat a bill that critics say would limit the reach of knock-off versions of biotech drugs.

May 29, 2013

Over-the-counter health-and-wellness items play a key role in bridging a supermarket retail pharmacy to the rest of the food store. And with extensive outcomesbased medicines on the horizon, more health-seeking consumers will look to make that link between pharmacy and nutrition.

Over-the-counter health-and-wellness items play a key role in bridging a supermarket retail pharmacy to the rest of the food store. And with extensive outcomesbased medicines on the horizon, more health-seeking consumers will look to make that link between pharmacy and nutrition.

 

May 14, 2013

A new infographic released Tuesday created by the Cardinal Health Foundation and The Ohio State University College of Pharmacy helps illustrate prescription drug abuse in the United States.

DUBLIN, Ohio — A new infographic released Tuesday created by the Cardinal Health Foundation and The Ohio State University College of Pharmacy helps illustrate prescription drug abuse in the United States.

Approximately 70% of people who abuse prescription medications get them from family or friends, often from medicine cabinets. On average, more than 10,000 people in the U.S. abuse prescription medications for the first time each day.

May 14, 2013

Finals can be a stressful time for any college or graduate student, with many hours spent studying and few spent socializing or relaxing. But many students are using prescription drugs to get through finals, according to a new study.

WASHINGTON — Finals can be a stressful time for any college or graduate student, with many hours spent studying and few spent socializing or relaxing. But many students are using prescription drugs to get through finals, according to a new study.

May 9, 2013

Declining use overall of healthcare services drove down spending on medicines in the United States by 3.5% per capita last year, according to a new study.

PARSIPPANY, N.J. — Declining use overall of healthcare services drove down spending on medicines in the United States by 3.5% per capita last year, according to a new study.

May 7, 2013

A Walgreens survey found that 37% of Medicare Part D beneficiaries have daily concerns about their prescription drug costs, and 1-in-5 say they’ve had to make sacrifices, such as delaying filling a prescription or skipping doses, to help manage medication costs.

DEERFIELD, Ill. — A Walgreens survey released Tuesday found that 37% of Medicare Part D beneficiaries have daily concerns about their prescription drug costs, and 1-in-5 say they’ve had to make sacrifices, such as delaying filling a prescription or skipping doses, to help manage medication costs.

That's almost 11.7 million seniors. 

May 7, 2013

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.

LONDON — The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.

The study, by British market research firm Visiongain, forecast that the $2.445 billion market size marked more than 20% of growth from 2012 and would account for about 2% of the overall market for biologics. The market is expected to grow rapidly through 2023 as biosimilars hit the market in the United States and European Union.

May 6, 2013

The Food and Drug Administration may soon find itself in another Plan-B-generated quandary — the complications around granting a three-year marketing exclusivity for a medicine that is both prescription-only and over-the-counter, according to an FDA Law Blog posted Sunday by Hyman, Phelps & McNamara.

WASHINGTON — The Food and Drug Administration may soon find itself in another Plan-B-generated quandary — the complications around granting a three-year marketing exclusivity for a medicine that is both prescription-only and over-the-counter, according to an FDA Law Blog posted Sunday by Hyman, Phelps & McNamara

May 6, 2013

Florida's state legislature approved a bill last week that will allow pharmacists to substitute biosimilars for brand name biotech drugs.

NEW YORK — Florida's state legislature approved a bill last week that will allow pharmacists to substitute biosimilars for brand name biotech drugs.

The bill, which was approved last Tuesday and is scheduled to take effect on July 1, institutes requirements for pharmacists to substitute biosimilars when they are determined to be biosimilar to and interchangeable with the brand name product, while also requiring the state board of pharmacy to maintain a current list of interchangeable products.

April 30, 2013

Teens looking for something to get them high score drugs from friends, from friends of friends, from networks on campus or at school, or from dealers on the street. But increasingly, they’re also turning to another source: Mom and dad’s medicine cabinet.

Teens looking for something to get them high score drugs from friends, from friends of friends, from networks on campus or at school, or from dealers on the street. But increasingly, they’re also turning to another source: Mom and dad’s medicine cabinet.

April 26, 2013

More than 1.3 million emergency room visits in 2010 were related to abuse of prescription drugs, and the problem has become widespread enough that the Centers for Disease Control and Prevention classifies it as an epidemic. In response, curbing abuse of prescription drugs has become a cornerstone of the Obama administration's drug policy.

WASHINGTON — More than 1.3 million emergency room visits in 2010 were related to abuse of prescription drugs, and the problem has become widespread enough that the Centers for Disease Control and Prevention classifies it as an epidemic. In response, curbing abuse of prescription drugs has become a cornerstone of the Obama administration's drug policy.

April 24, 2013

Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.

CHICAGO — Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.

The drug maker said it delivered more than 5 million doses of biosimilar medicines to patients in Europe and Australia. The convention includes multiple sessions devoted to such topics as biosimilar regulatory approval, manufacturing and market formation, the company said.

April 19, 2013

President Barack Obama sent his $3.8 trillion budget proposal to Congress on April 10, and the plan includes a number of provisions designed to cut spending on health care and promote health and wellness.

Overall, the budget is something of a mixed bag for the healthcare industry. While it would provide incentives for expanding the use of generic drugs, for example, it would also cut spending on Medicaid that have drawn opposition from pharmacy retailers, and even generic drug makers disagree with some of its provisions for that industry.

President Barack Obama sent his $3.8 trillion budget proposal to Congress on April 10, and the plan includes a number of provisions designed to cut spending on health care and promote health and wellness.

Overall, the budget is something of a mixed bag for the healthcare industry. While it would provide incentives for expanding the use of generic drugs, for example, it would also cut spending on Medicaid that have drawn opposition from pharmacy retailers, and even generic drug makers disagree with some of its provisions for that industry.

April 15, 2013

Generic makers heralded the fiscal year 2014 budget proposed last week by the Obama administration for its embrace of generic drugs, but were critical of its provisions on patent settlements and rebates.

WASHINGTON — Generic makers heralded the fiscal year 2014 budget proposed last week by the Obama administration for its embrace of generic drugs, but were critical of its provisions on patent settlements and rebates.

April 10, 2013

Legislation designed to limit the use of biosimilars has met defeat in Maryland.

WASHINGTON — Legislation designed to limit the use of biosimilars has met defeat in Maryland.

April 9, 2013

The new world of targeted, specialized medicines — many of them bioengineered and many of them aimed at smaller and smaller segments of the population — isn’t just on its way. It’s here. And it’s going to radically change the practice of pharmacy.

Here’s an eye-opener: Specialty drugs will likely account for 50% of all drug costs by 2018, up from 28.7% of total prescription drug costs in 2012.

The new world of targeted, specialized medicines — many of them bioengineered and many of them aimed at smaller and smaller segments of the population — isn’t just on its way. It’s here. And it’s going to radically change the practice of pharmacy.

Here’s an eye-opener: Specialty drugs will likely account for 50% of all drug costs by 2018, up from 28.7% of total prescription drug costs in 2012.

April 4, 2013

A committee of Florida's state Senate has passed a bill that could limit the use of biosimilars in the state.

WASHINGTON — A committee of Florida's state Senate has passed a bill that could limit the use of biosimilars in the state.

The Florida Senate Committee on Health Policy passed S.B. 732, sending it to the full state senate. The legislation would require pharmacists to inform doctors when a follow-on biologic was substituted for a brand-name biotech drug. The bill is similar to one signed into law last month by Virginia Gov. Bob McDonnell.